This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bukur, J. Articles by Seliger, B. Search for Related Content PubMed PubMed Citation Articles by Bukur, J. Articles by Seliger, B.

Functional Role of Human Leukocyte Antigen-G Up-Regulation in Renal Cell Carcinoma¹

Third Department of Internal Medicine, Johannes Gutenberg University, 55101 Mainz [J. B., C. H., B. S.]; Institute of Immunology, University Hospital of Essen, 43147 Essen [V. R., H. G-W.]; Department of Urology, University Hospital of Essen, 43147 Essen [H. L., H. R.]; Technical University, Institute of Virology, 81675 Munich [I. D.]; and Gesellschaft für Strahleuschulz-forschung Research Center, Institute of Molecular Virology, 81675 Munich [G. S.], Germany

The nonclassical HLA-G molecule exhibits a limited tissue distribution and exerts multiple immune regulatory functions. Recent studies indicate that HLA-G expression plays a key role in the induction of immune tolerance and may represent a novel immune escape mechanism of tumor cells. Despite a high frequency of tumor-infiltrating T lymphocytes in renal cell carcinoma (RCC) lesions, outgrowth of tumor cells occurs that might be attributable to abrogation-efficient antitumor responses. To delineate the potential role of HLA-G in RCC immunology, the HLA-G expression pattern and its functional consequences on immune responses were analyzed in cell lines and lesions derived from primary RCC lesions. A heterogeneous constitutive and IFN--inducible HLA-G mRNA and protein expression was found in 12.5% of RCC cell lines but not in autologous normal kidney cells. Western blot analysis of 37 primary RCC lesions revealed HLA-G protein expression in 27% of RCC lesions. Functional studies performed with alloreactive natural and lymphokine-activated killer cells as well as antigen-specific CD8⁺ T-cell populations demonstrated that HLA-G expression inhibits lysis of RCC cells by these different immune effector cells, whereas HLA-G^- normal kidney cells were recognized. Furthermore, the HLA-G-mediated counteraction of immune response could be restored by antibody blocking experiments. Thus, aberrant HLA-G expression is found at a relatively high frequency in RCC and might participate in evasion of these tumor cells from immunosurveillance.

This article has been cited by other articles:

				M.-Y. Cai, Y.-F. Xu, S.-J. Qiu, M.-J. Ju, Q. Gao, Y.-W. Li, B.-H. Zhang, J. Zhou, and J. Fan Human Leukocyte Antigen-G Protein Expression Is an Unfavorable Prognostic Predictor of Hepatocellular Carcinoma following Curative Resection Clin. Cancer Res., July 15, 2009; 15(14): 4686 - 4693. [Abstract] [Full Text] [PDF]

				E. D. Carosella, B. Favier, N. Rouas-Freiss, P. Moreau, and J. LeMaoult Beyond the increasing complexity of the immunomodulatory HLA-G molecule Blood, May 15, 2008; 111(10): 4862 - 4870. [Abstract] [Full Text] [PDF]

				A. Lin, W.-H. Yan, H.-H. Xu, M.-F. Gan, J.-F. Cai, M. Zhu, and M.-Y. Zhou HLA-G expression in human ovarian carcinoma counteracts NK cell function Ann. Onc., November 1, 2007; 18(11): 1804 - 1809. [Abstract] [Full Text] [PDF]

				U. Feger, E. Tolosa, Y.-H. Huang, A. Waschbisch, T. Biedermann, A. Melms, and H. Wiendl HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation Blood, July 15, 2007; 110(2): 568 - 577. [Abstract] [Full Text] [PDF]

				J. LeMaoult, J. Caumartin, M. Daouya, B. Favier, S. L. Rond, A. Gonzalez, and E. D. Carosella Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells Blood, March 1, 2007; 109(5): 2040 - 2048. [Abstract] [Full Text] [PDF]

				N. Rouas-Freiss, P. Moreau, S. Ferrone, and E. D. Carosella HLA-G Proteins in Cancer: Do They Provide Tumor Cells with an Escape Mechanism? Cancer Res., November 15, 2005; 65(22): 10139 - 10144. [Abstract] [Full Text] [PDF]

				J. LeMaoult, N. Rouas-Freiss, and E. D. Carosella HLA-G5 expression by trophoblast cells: the facts Mol. Hum. Reprod., October 1, 2005; 11(10): 719 - 722. [Full Text] [PDF]

				H. Nuckel, V. Rebmann, J. Durig, U. Duhrsen, and H. Grosse-Wilde HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia Blood, February 15, 2005; 105(4): 1694 - 1698. [Abstract] [Full Text] [PDF]